Acute pancreatitis during GLP-1 receptor agonist treatment. A case report

Glucagon-like peptide 1 receptor agonists (GLP-1RA) are the newest treatment for diabetes mellitus (DM). These drugs can down-regulate fasting glucose more than oral drugs and lead to more constant glucose levels compared to regular insulin. Acute pancreatitis is a serious condition that may have a...

Descripción completa

Detalles Bibliográficos
Autores principales: CHIS, BOGDAN AUGUSTIN, FODOR, DANIELA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808258/
https://www.ncbi.nlm.nih.gov/pubmed/29440961
http://dx.doi.org/10.15386/cjmed-804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808258/
https://www.ncbi.nlm.nih.gov/pubmed/29440961
http://dx.doi.org/10.15386/cjmed-804

Ejemplares similares